SARS-CoV-2 prevalence at eight urban health clinics in Nicaragua: possible implications for the COVID-19 pandemic.

Huete-Pérez, Jorge A; Colgrove, Robert C; Cabezas-Robelo, Cristiana; Páiz-Medina, Lucía; Hunsajarupan, Bhanasut; Silva, Sheyla; Quant, Carlos; Huete, Alejandra

Huete-Pérez, Jorge A; Colgrove, Robert C; Cabezas-Robelo, Cristiana; Páiz-Medina, Lucía; Hunsajarupan, Bhanasut; Silva, Sheyla; Quant, Carlos; Huete, Alejandra.

Afiliação

Huete-Pérez JA; Molecular Biology Center, University of Central America, Managua, Nicaragua.
Colgrove RC; Division of Infectious Diseases, Mount Auburn Hospital, Cambridge, MA, USA.
Cabezas-Robelo C; Harvard Medical School, Boston, MA, USA.
Páiz-Medina L; Molecular Biology Center, University of Central America, Managua, Nicaragua.
Hunsajarupan B; Molecular Biology Center, University of Central America, Managua, Nicaragua.
Silva S; Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Quant C; Vivian Pellas Hospital, Masaya, Nicaragua.
Huete A; Vivian Pellas Hospital, Masaya, Nicaragua.

IJID Reg ; 2: 110-117, 2022 Mar.

Article em En | MEDLINE | ID: mdl-35721440

Palavras-chave

COVID-19; LAMP; Latin America; Prevalence; Public health; Risk factors; SARS-CoV-2 infection; Serology

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies País/Região como assunto: America central / Nicaragua Idioma: En Revista: IJID Reg Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google